Login
Companies $NAUT
$2.89 +$0.45 (18.44%) Close
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

nautilus.bio

What Do They Do?

Develops a platform for measuring proteins and protein variants in biological samples, and provides analysis services to academic institutions, research organizations, and biopharmaceutical companies.

How Do They Make Money?

No revenue reported yet.

Who Are Their Customers?

Academic institutions, research organizations, and biopharmaceutical companies work with Nautilus through collaborations and the Early Access Program. Nautilus analyzes samples at its facility and delivers results through a cloud-based platform.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
vs $0 in Q3 FY2025
Net income
▲ +15% (Loss)
vs −$13.6M in Q3 FY2025

Services before platform sales The earlier plan described an expanded early-access phase leading to a broad launch of instruments, reagents, and software sold directly. The latest report describes fee-for-service sample analysis at Nautilus before broader platform commercialization.

Who Do They Compete With?

Competes with Thermo Fisher Scientific, Olink, Bruker, Agilent Technologies, Danaher, Becton, Dickinson, Quanterix, and Illumina

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support